| Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and … S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ... Journal of gastroenterology and hepatology 31 (5), 936-944, 2016 | 731 | 2016 |
| Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ... Hepatology 70 (4), 1457-1469, 2019 | 726 | 2019 |
| Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? A Lonardo, F Nascimbeni, A Mantovani, G Targher Journal of hepatology 68 (2), 335-352, 2018 | 663 | 2018 |
| NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Advances in therapy 34, 1291-1326, 2017 | 519 | 2017 |
| From NAFLD in clinical practice to answers from guidelines F Nascimbeni, R Pais, S Bellentani, CP Day, V Ratziu, P Loria, A Lonardo Journal of hepatology 59 (4), 859-871, 2013 | 492 | 2013 |
| Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease L Fedchuk, F Nascimbeni, R Pais, F Charlotte, C Housset, V Ratziu, ... Alimentary pharmacology & therapeutics 40 (10), 1209-1222, 2014 | 491 | 2014 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 309 | 2017 |
| Nonalcoholic fatty liver disease: Evolving paradigms A Lonardo, F Nascimbeni, M Maurantonio, A Marrazzo, L Rinaldi, ... World journal of gastroenterology 23 (36), 6571, 2017 | 243 | 2017 |
| Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms LE Adinolfi, R Zampino, L Restivo, A Lonardo, B Guerrera, A Marrone, ... World journal of gastroenterology: WJG 20 (13), 3410, 2014 | 203 | 2014 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 179 | 2022 |
| The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine … S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo Hepatology Research 46 (11), 1074-1087, 2016 | 174* | 2016 |
| Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ... Atherosclerosis 232 (1), 99-109, 2014 | 146 | 2014 |
| Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease F Nascimbeni, J Aron-Wisnewsky, R Pais, J Tordjman, C Poitou, ... BMJ open gastroenterology 3 (1), e000075, 2016 | 136 | 2016 |
| Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ... World journal of gastroenterology 22 (44), 9674, 2016 | 132 | 2016 |
| Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Metabolism 72, 57-65, 2017 | 131 | 2017 |
| Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis A Mantovani, F Nascimbeni, A Lonardo, G Zoppini, E Bonora, ... Thyroid 28 (10), 1270-1284, 2018 | 127 | 2018 |
| Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015 | 126 | 2015 |
| Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ... World journal of gastroenterology: WJG 20 (23), 7089, 2014 | 122 | 2014 |
| COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni, P Andreone Internal and emergency medicine 16, 281-308, 2021 | 88 | 2021 |
| A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? A Lonardo, S Lugari, S Ballestri, F Nascimbeni, E Baldelli, M Maurantonio Acta diabetologica 56 (4), 385-396, 2019 | 87 | 2019 |
